The results of a number of independent studies suggest that circulating regulatory peptides may be inactivated in the liver. Circulating levels of [Leu] ['2sI ]-Bolton and Hunter reagent are efficiently taken up by the isolated, perfused rat liver and then rapidly excreted in bile from where they can be recovered in a largely metabolised form. Short-chain gastrins and somatostatin also appear to be subject to hepatic inactivation.
Nothing is known of the enzymes responsible for hepatic peptide metabolism but the inactivation of regulatory peptides in the CNS has been extensively studied (see e.g. [5] ). For example, enkephalin inactivation in brain is mediated by the combined actions of aminopeptidase N (AP-N) and endopeptidase-24.11 (E-24.11; neprilysin) [6] and these same enzymes are also involved in the metabolism of CCK-8 in brain [7] . Although E-24.11 has a broad role in the inactivation of regulatory peptides the enzyme is present at extremely low levels in liver [8] . In contrast, AP-N has been located on the bile canalicular membrane [9] .
Proposing that some circulating peptides may be inactivated by hydrolysis at the bile canalicular membrane following internalisation via a transport protein in the sinusoidal membrane, we have prepared from rat liver a plasma membrane preparation approximately forty times enriched in the bile canalicular membrane [ 101 and examined this preparation for the presence of a number of membrane peptidases.
E-24. I 1 and angiotensin converting enzyme were assayed by using h.p.1.c. methods with [DAla', Leus]-enkephalin and HipHis-Leu as substrate respectively; enzyme specificities were controlled by inhibition with phosphoramidon (1 pM) and enalaprilat (10 pM). Membrane dipeptidase (MDP) was assayed by using Gly-D-Phe as substrate and specificity checked by inhibition by cilastatin (0.1 mM). Aminopeptidase P (AP-P) was assayed with Gly-Pro-Hypro (1 mM) as substrate. AP-N and dipeptidyl-peptidase IV (DPP-IV) were assayed by fluorimetnc methods.
Phosphoramidon-sensitive endothelin converting enzyme (ECE) activity was measured by a radioimmunoassay procedure in which the endothelin-l produced from big endothelin-l (1 pM) was quantified. ECE activity was distinguished from E-24.11 by its insensitivity to inhibition by IOpM thiorphan [I I].
The specific activities of the relevant peptidases are listed in Table 1 which also compares the comparable activities in a purified renal brush border membrane (P4) preparation. Several activities were not detectable in the canalicular plasma membranes; these were E-24.11, ACE and AP-P.ECE activity was detectable at levels comparable to its specific activity in lung membrane preparations (0.8+_0.05) pmol/min/mg; L.J. Murphy & A.J. Turner, unpublished observations). ECE activity is not measurable in kidney brush border membranes because of the very high concentrations of E-24.11 which rapidly degrade the endothelin product. Liver plasma membranes may therefore be a useful source of ECE free of contaminating E-24. I I . AP-N and DPP-IV were found to be abundant in the canalicular plasma membrane fractions consistent with earlier results. The AP-N activity was fully inhibited by 10 pM amastatin and the DPP-IV by a 1 hour pre-incubation with 1 mM diisopropylfluorophosphate. Hydrolysis of the E-24.11 substrate [D-AlaZ,LeuS]-enkephalin was observed by the canalicular plasma membrane preparation at levels in the range of 13-26 nmol/min/mg of protein although this activity was not inhibited by 10 pM phosphoramidon.
